Aquestive Therapeutics, Inc. AQST Lessee Operating Lease Liability Undiscounted Excess Amount
Lessee Operating Lease Liability Undiscounted Excess Amount at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s lessee operating lease liability undiscounted excess amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s lessee operating lease liability undiscounted excess amount?
- Aquestive Therapeutics, Inc. (AQST) reported lessee operating lease liability undiscounted excess amount of $2.61M in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s lessee operating lease liability undiscounted excess amount changed year-over-year?
- Aquestive Therapeutics, Inc.'s lessee operating lease liability undiscounted excess amount decreased by 22.4% year-over-year, from $3.36M to $2.61M.